When PrEP (pre-exposure prophylaxis) was released onto the market a decade ago, it was one of the greatest medical advances in the history of HIV (human immunodeficiency virus) — and it still is. If ...
Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...
The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and by 90% by 2030. Certain ...
Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback